Amir Avniel - Jun 30, 2022 Form 4 Insider Report for Beyond Air, Inc. (XAIR)

Signature
/s/ Amir Avniel
Stock symbol
XAIR
Transactions as of
Jun 30, 2022
Transactions value $
-$443,073
Form type
4
Date filed
7/5/2022, 04:45 PM
Previous filing
Mar 7, 2022
Next filing
Mar 15, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction XAIR Common Stock Sale -$426K -65.5K -13.83% $6.50 408K Jun 30, 2022 Direct F1, F2
transaction XAIR Common Stock Sale -$17.1K -2.6K -15.92% $6.57 13.7K Jun 30, 2022 Held by Dandelion Investments Ltd. F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sale was made to satisfy an Israeli tax obligation resulting from the reporting person's ownership of shares of Advanced Inhalation Therapies (AIT) Ltd., an Israeli corporation, which merged with Beyond Air, Inc. (formerly known as AIT Therapeutics, Inc.), a Delaware corporation, on January 13, 2017.
F2 The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.47 to $6.59, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
F3 The sale price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.57 to $6.585, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.